See more : Taiheiyo Cement Corporation (THYCF) Income Statement Analysis – Financial Results
Complete financial analysis of Tabula Rasa HealthCare, Inc. (TRHC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Tabula Rasa HealthCare, Inc., a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- Relo Group, Inc. (8876.T) Income Statement Analysis – Financial Results
- Triterras, Inc. (TRIT) Income Statement Analysis – Financial Results
- Technogym S.p.A. (TCCHF) Income Statement Analysis – Financial Results
- Oxford Technology Venture Capital Trust Plc (OXT.L) Income Statement Analysis – Financial Results
- TDC SOFT Inc. (4687.T) Income Statement Analysis – Financial Results
Tabula Rasa HealthCare, Inc. (TRHC)
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Website: https://www.tabularasahealthcare.com
About Tabula Rasa HealthCare, Inc.
Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. The company operates in two segments, CareVention HealthCare and MedWise HealthCare. It offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patient medication-related information; and MedWise medication therapy management software, a cloud-based platform designed to aid in the identification and resolution of medication and health-related problems. The company also provides TruChart that offers electronic health records (EHR), care coordination, and financial management in one program allowing Programs of All-Inclusive Care for the Elderly (PACE) to track measurable outcomes in defined timeframes for the populations they serve; and PACElogic, which delivers sharable workflows comprising EHR, customer relationship management, claims adjudication, electronic data interchange, care management, coordination and planning, integration with community-based providers, and various federal and state that requires reporting. In addition, it offers DoseMeRx, a decision support software that leverages clinically validated pharmacokinetic drug models, patient characteristics, drug concentrations, and genotypes to guide dose optimization; and PrescribeWellness, a PrescribeWellness, a patient engagement center platform. Further, the company provides clinical pharmacist collaboration, prescription fulfillment and adherence packaging, and pharmacy benefit management services, as well as health plan management services, including risk adjustment and third party administrator services. As of December 31, 2021, it served approximately 150 healthcare organizations; and 350 health plans and approximately 18,000 retail pharmacies. The company provides cloud-based software applications to assist prescribers and pharmacists. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 299.52M | 331.26M | 297.22M | 284.71M | 204.27M | 134.55M | 94.06M | 70.04M | 48.43M | 25.14M |
| Cost of Revenue | 232.60M | 233.36M | 204.81M | 181.36M | 137.67M | 93.66M | 65.18M | 49.13M | 37.81M | 20.92M |
| Gross Profit | 66.91M | 97.90M | 92.41M | 103.35M | 66.60M | 40.89M | 28.89M | 20.91M | 10.62M | 4.22M |
| Gross Profit Ratio | 22.34% | 29.56% | 31.09% | 36.30% | 32.60% | 30.39% | 30.71% | 29.86% | 21.92% | 16.79% |
| Research & Development | 14.48M | 19.79M | 18.18M | 21.74M | 12.22M | 5.63M | 3.81M | 2.88M | 1.66M | 1.34M |
| General & Administrative | 74.97M | 73.76M | 65.38M | 50.90M | 28.18M | 21.18M | 11.83M | 7.12M | 3.97M | 2.48M |
| Selling & Marketing | 10.49M | 25.97M | 21.55M | 25.27M | 9.67M | 5.54M | 3.86M | 2.88M | 2.27M | 1.78M |
| SG&A | 85.47M | 99.73M | 86.93M | 76.17M | 37.85M | 26.72M | 15.69M | 10.00M | 6.24M | 4.26M |
| Other Expenses | 23.35M | 47.71M | 45.04M | 34.28M | 16.80M | 0.00 | 639.00K | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 123.30M | 167.23M | 150.15M | 132.19M | 66.87M | 41.86M | 24.62M | 16.81M | 9.72M | 6.71M |
| Cost & Expenses | 355.90M | 400.58M | 354.96M | 313.54M | 204.54M | 135.52M | 89.79M | 65.93M | 47.53M | 27.63M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 9.03M | 9.11M | 20.74M | 15.99M | 906.00K | 688.00K | 4.49M | 5.92M | 1.35M | 833.00K |
| Depreciation & Amortization | 31.74M | 47.71M | 45.04M | 34.28M | 16.80M | 9.51M | 5.12M | 3.93M | 1.82M | 1.12M |
| EBITDA | -24.64M | -21.62M | -20.35M | 1.63M | 16.53M | 8.54M | 3.89M | 8.04M | 2.71M | -1.76M |
| EBITDA Ratio | -8.23% | -6.53% | -4.27% | 1.91% | 8.09% | 6.35% | 9.98% | 11.48% | 5.60% | -5.46% |
| Operating Income | -56.38M | -69.32M | -57.74M | -28.83M | -49.74M | 5.20M | 4.55M | 6.17M | 107.00K | -2.49M |
| Operating Income Ratio | -18.82% | -20.93% | -19.43% | -10.13% | -24.35% | 3.87% | 4.84% | 8.80% | 0.22% | -9.91% |
| Total Other Income/Expenses | -20.56M | -9.11M | -20.74M | -15.99M | -906.00K | -688.00K | -10.26M | -6.64M | -2.41M | -1.38M |
| Income Before Tax | -76.95M | -78.43M | -86.13M | -48.64M | -50.65M | 4.51M | -5.71M | -2.54M | -1.52M | -3.87M |
| Income Before Tax Ratio | -25.69% | -23.68% | -28.98% | -17.08% | -24.79% | 3.35% | -6.07% | -3.62% | -3.13% | -15.40% |
| Income Tax Expense | 389.00K | 627.00K | -5.17M | -16.20M | -3.38M | -9.78M | 541.00K | 328.00K | -409.00K | 833.00K |
| Net Income | -77.33M | -79.06M | -80.97M | -32.44M | -47.27M | 14.30M | -6.25M | -2.86M | -1.11M | -3.87M |
| Net Income Ratio | -25.82% | -23.86% | -27.24% | -11.39% | -23.14% | 10.63% | -6.64% | -4.09% | -2.29% | -15.40% |
| EPS | -3.18 | -3.39 | -3.71 | -1.57 | -2.48 | 0.76 | -0.83 | -0.29 | -0.11 | -0.39 |
| EPS Diluted | -3.18 | -3.39 | -3.71 | -1.57 | -2.48 | 0.68 | -0.54 | -0.29 | -0.11 | -0.39 |
| Weighted Avg Shares Out | 24.29M | 23.29M | 21.82M | 20.62M | 19.10M | 16.73M | 7.49M | 9.86M | 9.86M | 9.86M |
| Weighted Avg Shares Out (Dil) | 24.29M | 23.29M | 21.82M | 20.62M | 19.10M | 18.77M | 11.59M | 9.86M | 9.86M | 9.86M |
ArchCare Extends Contract with Tabula Rasa HealthCare for Medication Safety, Efficacy, and Adherence Services
Renewed Focus on Home and Community Based Care Drives Expanded Interest in New PACE Plans
New Study Predicts Risks of Drug Interactions without Exposing Patients to Harm
Tabula Rasa HealthCare, Inc. (TRHC) CEO Calvin Knowlton on Q1 2021 Results - Earnings Call Transcript
Tabula Rasa Healthcare (TRHC) Reports Q1 Loss, Tops Revenue Estimates
Tabula Rasa HealthCare Reports First Quarter 2021 Results
Analysts Estimate Tabula Rasa Healthcare (TRHC) to Report a Decline in Earnings: What to Look Out for
Tabula Rasa HealthCare First Quarter 2021 Earnings Conference Call Announcement
Tabula Rasa HealthCare and OneOme Combine Powerful Precision Medication Tools to Improve Medication Safety, Efficacy and Adherence
Tabula Rasa HealthCare Expands COVID-19 Vaccine Support Services to Community Pharmacies
Source: https://incomestatements.info
Category: Stock Reports